Warfarin can continue through cardiac rhythm device implantation
28 July 2009
| by Amy Corderoy
Anti-arrhythmia devices can be implemented safely in high thromboembolic risk patients without the interrupting warfarin therapy, a pilot study has found....
Want to read complete article? Please Sign in or Register.